Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa

Dermatol Ther. 2020 Jul;33(4):e13756. doi: 10.1111/dth.13756. Epub 2020 Jun 29.

Authors

Matteo Megna¹, Angelo Ruggiero¹, Adriana Di Guida¹, Angela Patrì¹, Gabriella Fabbrocini¹, Claudio Marasca¹

Affiliation

¹ Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

PMID: 32495491
DOI: 10.1111/dth.13756

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Hidradenitis Suppurativa* / diagnosis
Hidradenitis Suppurativa* / drug therapy
Humans
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
ixekizumab